Evaluation of different strategies for post-exposure treatment of Ebola virus infection in rodents
Gary Wong, Jason Richardson, Jane Ennis, Jeffrey D. Turner, James Strong and Gary P. Kobinger Journal of Bioterrorism and Biodefense 2011 S1: 007
http://www.omicsonline.org/2157-2526/2157-2526-S1-007.pdf
Use of Recombinant Adenovirus Vectored Consensus IFN-a to Avert Severe Arenavirus Infection
Brian B. Gowen, Jane Ennis, Andrew Russell, Eric J. Sefing, Min-Hui Wong, Jeffrey Turner
PLoS ONE 2011 6(10): e26072
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026072
Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201)
Donald F. Smee, Min-Hui Wong, Andrew Russell, Jane Ennis, Jeffrey D. Turner
PLoS ONE 2011 6(10): e26330
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026330
Treatment of Yellow Fever Virus with an Adenovirus-Vectored Interferon, DEF201, in a Hamster Model
Justin G. Julander, Jane Ennis, Jeffrey Turner, and John D. Morrey
Antimicrobial Agents and Chemotherapy 2011 55(5): 2067-2073
http://aac.asm.org/content/55/5/2067.full
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
Yohichi Kumaki, Jane Ennis, Ramtin Rahbar, Jeffrey D. Turner, Miles K. Wandersee,
Aaron J. Smith, Kevin W. Bailey, Zachary G. Vest, Jason R. Madsen, Joseph K.-K. Li, Dale L. Barnard
Antiviral Research 2011 89: 75-82
http://www.sciencedirect.com/science/article/pii/S0166354210008090
